Intellectual Property India Publishes Patent Application for 'Modified Rhabdovirus Glycoproteins And Uses Thereof' Filed by Regeneron Pharmaceuticals, Inc.; and Vyriad, Inc.

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517079780 A) filed by Regeneron Pharmaceuticals, Inc.; and Vyriad, Inc., Tarrytown, U.S.A., on Aug. 22, for 'modified rhabdovirus glycoproteins and uses thereof.'

Inventor(s) include Buehler, Jason; Russell, Stephen J.; Nenavath, Gopal Naik; Moy, Melissa; Ziegler, Chris; and Vandergaast, Rianna.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides recombinant fusogenic proteins comprising a rhabdovirus glycoprotein (G) and a targeting molecule attached to the N-terminus of the rhabdovirus glycoprotein. Further pro...